- 6 of 11 Patients in the Pilot Phase Experienced a Partial Response, with 4 Confirmed; One Patient Experienced Resolution of the Hepatic Metastatic Lesion - - Data Presented at AACR Special ...
Over the weekend, Bristol Myers Squibb & Co (NYSE:BMY) shared preliminary data from a Phase 1 study of CC-97540 (BMS-986353), a CD19-directed CAR T Cell Therapy Manufactured Using a Next-generation ...
Mechelen, Belgium; June 14, 2024, 22:01 CET; Galapagos NV (GLPG) today announced that it will present encouraging new data from the ongoing Phase 1/2 ATALANTA-1 study of CD19 CAR-T candidate, GLPG5101 ...
– Compelling early clinical response signals for VIR-5818 and VIR-5500 in heavily pretreated patients with various solid tumors VIR-5818: In patients receiving doses ≥400 µg/kg, tumor shrinkage ...
WASHINGTON, Dec. 17, 2025 /PRNewswire/ -- New data from the 2025 Monitoring the Future Survey indicating use of most drugs remains low among U.S. teens and the number of youth choosing to abstain from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results